A synthesized peptide derived from human CD162 A SLe (x) -type proteoglycan, which through high affinity, calcium-dependent interactions with E-, P- and L-selectins, mediates rapid rolling of leukocytes over vascular surfaces during the initial steps in inflammation. Critical for the initial leukocyte capture.
Alternative Names:
CD162, CLA, PSGL 1, PSGL1, selectin P ligand, SELPLG
Boster Bio Anti-CD162 Monoclonal Antibody catalog M03674-1. Tested in WB, IHC, ICC/IF, IP applications. This antibody reacts with Human.
